| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/03/2009 | US7485297 Method of inhibition of vascular development using an antibody |
| 02/03/2009 | US7485291 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| 02/03/2009 | CA2291883C Trigger factor expression plasmids |
| 02/03/2009 | CA2261994C Frozen food product containing heat stable antifreeze protein |
| 02/03/2009 | CA2185565C Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 02/03/2009 | CA2177600C Regulatory nucleic acid sequences and uses thereof |
| 02/03/2009 | CA2152066C Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 02/03/2009 | CA1341590C Human immune interferon |
| 01/29/2009 | WO2009015163A1 Recombinant peptide production using a cross-linkable solubility tag |
| 01/29/2009 | WO2009015011A1 Natriuretic polypeptides |
| 01/29/2009 | WO2009014782A2 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| 01/29/2009 | WO2009014216A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
| 01/29/2009 | WO2009013066A1 Method for fermenting cell cultures |
| 01/29/2009 | WO2009012600A1 Fusion proteins |
| 01/29/2009 | WO2009012588A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | WO2008156763A3 Human neutralizing monoclonal antibodies to h5n1 influenza a virus |
| 01/29/2009 | WO2007095749A8 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 01/29/2009 | US20090031454 Fatty Acid Hydroxylases and Uses Thereof |
| 01/29/2009 | US20090031445 Methods to enhance plant trauma resistance |
| 01/29/2009 | US20090030188 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090030184 Expression system for producing collagen |
| 01/29/2009 | US20090030183 Interferon Beta-Like Molecules |
| 01/29/2009 | US20090030182 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090029916 Fibroblast Growth Factor-14 |
| 01/29/2009 | US20090029907 Recombinant Method for Production of an Erythropoiesis Stimulating Protein |
| 01/29/2009 | US20090029458 Chicken leukemia inhibitory factor (LIF) and gene thereof |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029420 solubility tag characterized by an increase in acid resistance; production and recovery of fusion peptide; inclusion body tag's resistance to acid hydrolysis facilitates easier and cleaner separation of the peptide of interest after acid hydrolysis |
| 01/29/2009 | US20090029419 Expression of modified antibodies in avian cells |
| 01/29/2009 | US20090029418 Method for cloning and expression of stui restriction endonuclease and stui methylase in e. coli |
| 01/29/2009 | US20090029417 Recombinant Microorganism |
| 01/29/2009 | US20090029416 Hyperthermostable protease gene |
| 01/29/2009 | US20090029415 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/29/2009 | US20090029414 Cell-free synthesis of membrane bound polypeptides |
| 01/29/2009 | US20090029413 have desirable characteristics regarding adherence to the substrate, durability, hydrophilicity, wettability, biocompatibility and permeability and are thus particularly useful as ophthalmic devices such as contact lenses; low spoilation with respect to cell debris, cosmetics, tear components, lipids |
| 01/29/2009 | US20090029412 for the generation of insoluble fusion peptides; used for the expression and recovery of any bioactive peptides and proteins that are recombinantly expressed |
| 01/29/2009 | US20090029411 Biomaterial Capable Of Successively Performing A Solution/Gel Transition And Then A Gel/Solution Transition |
| 01/29/2009 | US20090029396 Assay kit and antibody for human low molecular weight CD14 |
| 01/29/2009 | US20090029380 HUMAN MutY |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090029343 Methods for isolation and analysis of sialylated and phosphorylated peptides |
| 01/29/2009 | US20090029004 Phytase variants |
| 01/29/2009 | US20090028893 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 01/29/2009 | US20090028884 Oligomeric receptor ligand pair member complexes |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | US20090028881 Conjugate of an antibody against CCR5 and an antifusogenic peptide |
| 01/29/2009 | US20090028880 Serum albumin binding proteins |
| 01/29/2009 | US20090028877 Antibody Composition Specifically Binding to Ganglioside Gm |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028859 Bispecific antibodies that bind to vegf receptors |
| 01/29/2009 | US20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 01/29/2009 | US20090028851 Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein |
| 01/29/2009 | US20090028822 Glycopegylated Interferon Alpha |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | CA2720628A1 Fusion proteins |
| 01/29/2009 | CA2694466A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | CA2694397A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv) and use thereof |
| 01/29/2009 | CA2693303A1 Natriuretic polypeptides |
| 01/29/2009 | CA2685308A1 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| 01/28/2009 | EP2019115A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/28/2009 | EP2018437A2 Non-natural amino acid substituted polypeptides |
| 01/28/2009 | EP2018429A1 Genetically encoded fluorescent coumarin amino acids |
| 01/28/2009 | EP2018423A1 Method for extracting components from a yeast cell culture |
| 01/28/2009 | EP2018184A2 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases |
| 01/28/2009 | EP2018174A2 Compositions and methods for producing fermentation products and residuals |
| 01/28/2009 | EP1446426B1 Peptide purification by means of metal ion affinity chromatography |
| 01/28/2009 | EP0675953B1 Soluble peptides having constrained, secondary conformation in solution and method of making same |
| 01/28/2009 | CN101353688A Preparation and use of kudzu root peptides |
| 01/28/2009 | CN101353687A Melissa powder peptides having angiotensin transferase inhibitory activity and preparation thereof |
| 01/28/2009 | CN101353686A Production method of haemachrome and decolorizing blood plasma albumen powder |
| 01/28/2009 | CN101353685A Zein active peptide and preparation technique thereof |
| 01/28/2009 | CN101353684A Technology for extracting protein in pine caterpillar using alkali proteinase method |
| 01/28/2009 | CN101353681A Method for preparing nitrogen-containing starch syrup by peeled and degermed maize flour polyzyme method |
| 01/28/2009 | CN101353641A Method for improving RTN4B protein yield |
| 01/28/2009 | CN101353633A Lactobacillus plantarum ZJ316, procreant antibiotic peptides, preparation and use thereof |
| 01/28/2009 | CN101353381A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 01/28/2009 | CN101353380A Jellyfish origin immune activity enhanced collagen peptide, preparation and use thereof |
| 01/28/2009 | CN100455599C Gene recombinant antibody and its fragment |
| 01/28/2009 | CN100455597C Process of high purity albumin production |
| 01/28/2009 | CN100455596C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/27/2009 | US7482440 Hemopoietin receptor protein, NR10 |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482431 KCNQ2 potassium channels |
| 01/27/2009 | US7482428 Optimized expression of HPV 31 L1 in yeast |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482147 polypeptides, proteins or fusion proteins having hydrolase enzyme activity, used for medical diagnosis and therapy |
| 01/27/2009 | US7482141 Methods and compositions for vitamin K epoxide reductase |
| 01/27/2009 | US7482140 culturing Escherichia comprising a mutant prephenate dehydrogenase which is desensitized to feedback inhibition by tyrosine |
| 01/27/2009 | US7482139 Variants of antithrombin III |
| 01/27/2009 | US7482138 PAK5-related compositions and methods |
| 01/27/2009 | US7482137 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 01/27/2009 | US7482017 isolated attenuated flaviviruses , such as West Nile viruses, having modifications that provide phenotypic varation, particularly in comparison to a more virulent reference strains. The invention encompasses the isolated viruses and immunogenic compositions thereof, in addition methods to produce same |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | US7482006 Culturing yeasts, host cells; biosynthesis |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2360762C Sebocytes, sebocyte cell lines and applications thereof |